Mangoceuticals, Inc.'s total assets for Q2 2026 were $14.17M, a decrease of -1.91% from the previous quarter. MGRX total liabilities were $1.65M for the fiscal quarter, a 69.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.